about
Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertensionExtending the scope of pooled analyses of individual patient biomarker data from heterogeneous laboratory platforms and cohorts using merging algorithms.Hypoxia induces dilated cardiomyopathy in the chick embryo: mechanism, intervention, and long-term consequencesImplementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practiceModeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsiaAngiogenic factors and the risk of adverse outcomes in women with suspected preeclampsiaCirculating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia.Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia.Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.Update on the pathophysiological implications and clinical role of angiogenic factors in pregnancy.OS066. Intrauterine CYP2J2 expression and circulatingepoxyeicosatrienoic acid levels in preeclampsia.The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction.Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the sFlt-1/ PlGF Ratio in Singleton Pregnancies.PP059. Angiogenic factors and risk of preeclampsia related adverse outcomes in twin pregnancies.PP051. Prediction of preeclampsia with the sFlt-1/PLGF ratio: impact of the slope of repeated measurements.Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies.Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia.Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries.Automated measurement of sFlt1, PlGF and sFlt1/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders.Effects of circulating and local uteroplacental angiotensin II in rat pregnancy.Uterine vascular function in a transgenic preeclampsia rat model.Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia.Natural Killer Cell Reduction and Uteroplacental Vasculopathy.SLC41A1 is the only magnesium responsive gene significantly overexpressed in placentas of preeclamptic women.Author's reply re: Pre-eclampsia is primarily a placental disorder: FOR: Pre-eclampsia is primarily a placental disorder.Pre-eclampsia is primarily a placental disorder: FOR: Pre-eclampsia is primarily a placental disorder.Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies.Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia.Re: Screening for pre-eclampsia using sFlt-1/PlGF ratio cut-off of 38 at 30-37 weeks' gestation.Angiogenic Markers and Cardiovascular Indices in the Prediction of Hypertensive Disorders of Pregnancy.Re: uterine artery Doppler and sFlt-1/PlGF ratio: usefulness in diagnosis of pre-eclampsia. P. I. Gómez-Arriaga, I. Herraiz, E. A. López-Jiménez, E. Gómez-Montes, B. Denk and A. Galindo. Ultrasound Obstet Gynecol 2013; 41: 530-537.Changes in endovascular trophoblast invasion and spiral artery remodelling at term in a transgenic preeclamptic rat model.Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and Time to Delivery in Women With Suspected Preeclampsia.Endovascular trophoblast invasion, spiral artery remodelling and uteroplacental haemodynamics in a transgenic rat model of pre-eclampsia.Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1/PlGF ratio: Diagnostic accuracy of the automated immunoassay Kryptor®.Re: Rational and irrational ratios.Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.Re: Longitudinal changes in maternal soluble endoglin and angiopoietin-2 in women at risk for pre-eclampsia. A. Khalil, N. Maiz, R. Garcia-Mandujano, M. Elkhouli and K. H. Nicolaides. Ultrasound Obstet Gynecol 2014; 44: 402-410.
P50
Q28575913-DCE2E872-4D07-4C95-8980-20FC6473FC58Q31054746-83453736-7A32-4CF2-A6CF-B43877EACECCQ33428551-E4D813C1-AD2A-4C71-B822-84D76BE6663AQ35204444-5ED86AFA-4F56-416E-AC53-A6FDCFFFFF5FQ35538277-9383E86C-FDBE-41C6-B9AF-7A66B5A1CCF1Q35871381-A11F931F-3893-46D4-9FDF-7DEF7A00B18CQ36204596-D7E7BC0D-9D4B-4DF3-90B2-8D91657C456FQ36528411-9496B5C3-4C3B-43CA-89E9-19A79AC58035Q37098433-1BF75D82-BC2B-481B-A61D-A6F00983EE3DQ37642785-0CDA878E-9CE5-4DF4-B91B-C87453180106Q37935034-A17517A9-24D4-415D-82C5-92AB081B7040Q38346796-B69D052D-5FC9-4785-BB88-476D54216127Q39322724-FF534A1A-F81D-4578-AE6E-230BA55E5493Q39369879-5B0C51C5-AF66-4A6C-909E-461A71D5CFF4Q39442263-2EFB8EB6-7614-4215-A020-F78C2E537D91Q40805033-F0F92097-0245-4243-85C0-E79FE630B102Q40805049-6C792EED-4087-4CD1-8755-D077F733CB12Q41709450-801682F7-0149-4E2C-BAFE-EC765EC7FE92Q44121356-6F0B1799-A412-4DCA-8402-C19908DDC98AQ45012640-5ABD6507-4B6E-470D-B6C7-BAF5DE4B840EQ45835216-CB7A5007-BC34-4379-A616-3A884AE61E14Q46588322-F5389BEC-9A15-4127-918E-22181672426EQ46808246-4FD1B2F4-912C-4289-B515-98E3B0BA68B8Q47187556-CA39EB64-7998-43E5-B54F-A4B9AA095AD3Q48018118-64CB33FD-51DD-4726-967B-4E62F1893B28Q48026698-8DCC27CA-29B9-4EE6-885E-79459C5B2BA5Q49848401-92C696F5-3168-408D-B643-185D7D21B95CQ50045006-104D9C6D-4BDB-41F5-8E1C-3BDCF829EB3DQ50947119-EAF248D2-CBB6-4EA2-8B9C-2730649E27D5Q51008525-281A7B8F-57AA-49D4-8369-A8B526FF0FADQ51021002-B20F5557-FBB1-4FAF-9F91-2B1966121A7CQ51025132-A42DFA97-AB84-4C90-9A41-E122082DE278Q51050624-6C6DFBE8-E68C-446F-AFF5-8762B0AA5B2AQ51584328-A2191184-6C23-4876-8A27-C35692BCB034Q51650284-5516DBE1-94D1-42F3-A47D-A76194DC0FF8Q51701103-D10ED00C-2F4D-4E70-9DCD-90ADBE010C02Q52839241-079A3026-8EF6-4481-897A-2CA30876131EQ52842919-043C40D5-6506-4038-82E3-CBFC350B02D3Q52858097-0C052BB2-FCD7-4935-AE7E-2FBB47536115Q52873464-0BD036D7-7104-4FDF-B6EB-9CA720AA0904
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Stefan Verlohren
@ast
Stefan Verlohren
@en
Stefan Verlohren
@es
Stefan Verlohren
@nl
Stefan Verlohren
@sl
type
label
Stefan Verlohren
@ast
Stefan Verlohren
@en
Stefan Verlohren
@es
Stefan Verlohren
@nl
Stefan Verlohren
@sl
prefLabel
Stefan Verlohren
@ast
Stefan Verlohren
@en
Stefan Verlohren
@es
Stefan Verlohren
@nl
Stefan Verlohren
@sl
P214
P106
P108
P21
P214
P31
P496
0000-0003-3507-8636
P735
P7859
viaf-38020019